Cutaneous malignant tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with primary skin-derived malignant tumors through skin tissue pathological biopsy include epidermal malignant tumors, malignant tumors of skin appendages, malignant melanoma, malignant vascular tumors, neurogenic and neuroendocrine malignant tumors, smooth muscle and adipose tissue malignant tumors, fibrous connective tissue malignant tumors, and cutaneous lymphomas, etc. 2. Sign the informed consent form (the retrospective registration registration part can be exempted from informed consent).
Exclusion criteria
Exclusion criteria: 1. Without a pathological diagnosis of skin tissue 2. Suffering from a special genetic syndrome that increases the risk of developing skin malignancies, such as dyschromic ichthyosis, basal cell nevus syndrome, ocular-skin albinism, dystrophic epidermolysis bullosa, Bazex-Dupre-Christol syndrome, etc. 3. Skin tumors that are not originated from the skin 4. Unable to cooperate due to cognitive dysfunction and without the assistance of family members
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| European organisation for research and treatment of cancer core quality of life;Dermatology life quality index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Size of cutaneous tumors;Complete response;Recurrence-free survival; | — |
Countries
China
Contacts
Beijing Hospital